![]() |
Volumn 2, Issue , 2005, Pages 0287-0288
|
The benefits of artemisinin combination therapy for malaria extend beyond the individual patient
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMODIAQUINE;
ARTEMETHER;
ARTEMISININ DERIVATIVE;
ARTESUNATE;
BENFLUMETOL;
PYRIMETHAMINE;
ANTIINFECTIVE AGENT;
ARTEMISININ;
SESQUITERPENE;
ANTIMALARIAL ACTIVITY;
CLINICAL TRIAL;
DISEASE DURATION;
DRUG COST;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
GAMETOCYTE;
HUMAN;
INFECTION CONTROL;
MALARIA;
MOSQUITO;
PARASITE TRANSMISSION;
PARASITE VECTOR;
PARASITE VIRULENCE;
PLASMODIUM FALCIPARUM;
SHORT SURVEY;
ANIMAL;
ARTICLE;
DRUG COMBINATION;
GAMETOGENESIS;
HEALTH CARE POLICY;
MALARIA FALCIPARUM;
PATHOGENICITY;
PUBLIC HEALTH;
ANIMALS;
ANTI-INFECTIVE AGENTS;
ARTEMISININS;
DRUG THERAPY, COMBINATION;
GAMETOGENESIS;
HEALTH POLICY;
HUMANS;
MALARIA, FALCIPARUM;
PLASMODIUM FALCIPARUM;
PUBLIC HEALTH;
SESQUITERPENES;
|
EID: 19344375409
PISSN: 15491277
EISSN: None
Source Type: Journal
DOI: 10.1371/journal.pmed.0020105 Document Type: Short Survey |
Times cited : (24)
|
References (9)
|